营养试验 (myEloproliferative Neoplasms中的营养干预):关于可行性和坚持性的随机第一阶段试验研究的结果
Laura F Mendez Luque1,2, Julio Avelar-Barragan3, Hellen Nguyen1
1University of California, Irvine School of Medicine, Irvine, California.
Cancer research communications
|February 23, 2024
概括
地中海饮食对于骨髓增殖性新生瘤 (MPN) 患者来说是可行的,改善了症状负担. 这种低风险的营养方法对MPN管理和其他血液病状有很大的希望.
科学领域:
- 血液学 血液学 血液学
- 营养科学 营养科学
- 炎症研究 炎症研究
背景情况:
- 慢性炎症是髓增殖性新生体 (MPN) 发病的关键.
- 目前的治疗方法,如JAK抑制剂,具有显著的副作用.
- 营养提供了一个低风险的策略,以减少炎症和管理MPN症状.
研究的目的:
- 评估地中海饮食干预措施对MPN患者的可行性.
- 为了比较地中海饮食和美国标准饮食指南之间的坚持和症状负担.
- 探索饮食对MPN炎症生物标志物和肠道微生物群的影响.
主要方法:
- 随机,并行手臂研究,将地中海饮食与美国农业部指导方针进行比较.
- 为两组人群提供平等的教育和营养师咨询.
- 在15周内评估可行性,坚持性和症状负担;采集生物样本.
主要成果:
- 地中海饮食对MPN患者来说与标准的美国农业部饮食一样可行.
- 实现了对地中海饮食的高度坚持 (≈80%).
- 症状负担在两组中都得到改善;炎症性细胞因子或肠道微生物组没有显著变化.
结论:
- 在适当的支持下,MPN患者可以坚持地中海饮食.
- 饮食干预显示出作为MPN护理的一部分的潜力.
- 需要进一步研究饮食对血液学疾病的影响.
相关概念视频
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Bioavailability Study Design: Single Versus Multiple Dose Studies
390
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
390
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252


